(approved in combination with meropenem)and lefamulin,7 represent new chemical classes and therefore meet one of the four innovation criteria.Most recently approved agents are deriva 133、tives of known classes,including combination of the penicillin analogue sulbactam with the diazabicyclooctane(DBO)...